Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 6/2016

01-12-2016 | Research Article

Knowledge and pharmacological management of Alzheimer’s disease by managing community pharmacists: a nationwide study

Authors: Natalie Zerafa, Charles Scerri

Published in: International Journal of Clinical Pharmacy | Issue 6/2016

Login to get access

Abstract

Background Managing community pharmacists can play a leading role in supporting community dwelling individuals with Alzheimer’s disease and their caregivers. Objective The main purpose of this study was to assess knowledge of managing community pharmacists towards Alzheimer’s disease and its pharmacological management. Setting Community pharmacies in the Maltese islands. Method A nationwide survey was conducted with full-time managing community pharmacists in possession of a tertiary education degree in pharmacy studies. The level of knowledge was investigated using the Alzheimer’s Disease Knowledge Scale and the Alzheimer’s Disease Pharmacotherapy Measure. Participants were also asked to rate a number of statements related to disease management. Results Maltese managing community pharmacists (57 % response rate) had inadequate knowledge on risk factors, caregiving issues and pharmacological management of Alzheimer’s disease. Age and number of years working in a community pharmacy setting were found to be negatively correlated with increased knowledge. Conclusion The findings highlight the need of providing training and continued educational support to managing community pharmacists in order to provide quality advice to individuals with dementia and their caregivers in the community.
Literature
1.
go back to reference Hofman A, Ott A, Breteler MMB, Bots ML, Slooter AJ, van Harskamp F, et al. Atherosclerosis, apolipoprotein E and prevalence of dementia and Alzheimer’s disease in the Rotterdam study. Lancet. 1997;349:151–4.CrossRefPubMed Hofman A, Ott A, Breteler MMB, Bots ML, Slooter AJ, van Harskamp F, et al. Atherosclerosis, apolipoprotein E and prevalence of dementia and Alzheimer’s disease in the Rotterdam study. Lancet. 1997;349:151–4.CrossRefPubMed
2.
go back to reference McGuffey EC. Alzheimer’s disease: an overview for the pharmacist. J Am Pharm Assoc (Wash). 1997;NS37:347–52.CrossRef McGuffey EC. Alzheimer’s disease: an overview for the pharmacist. J Am Pharm Assoc (Wash). 1997;NS37:347–52.CrossRef
4.
go back to reference Cummings JL, Mackell J, Kaufer D. Behavioral effects of current Alzheimer’s disease treatments: a descriptive review. Alzheimer’s Dement. 2008;4:49–60.CrossRef Cummings JL, Mackell J, Kaufer D. Behavioral effects of current Alzheimer’s disease treatments: a descriptive review. Alzheimer’s Dement. 2008;4:49–60.CrossRef
5.
go back to reference Scerri A, Scerri C. Dementia in Malta: new prevalence estimates and projected trends. Malta Med J. 2012;24:21–4. Scerri A, Scerri C. Dementia in Malta: new prevalence estimates and projected trends. Malta Med J. 2012;24:21–4.
6.
go back to reference Scerri C. Empowering change: a national strategy for dementia in the Maltese Islands. Valletta: Parliamentary Secretariat for the Rights of Persons with Disability and Active Ageing; 2015. Scerri C. Empowering change: a national strategy for dementia in the Maltese Islands. Valletta: Parliamentary Secretariat for the Rights of Persons with Disability and Active Ageing; 2015.
7.
go back to reference Skelton J. White paper on expanding the role of pharmacists in caring for individuals with Alzheimer’s disease. J Am Pharm Assoc. 2008;48:715–21.CrossRef Skelton J. White paper on expanding the role of pharmacists in caring for individuals with Alzheimer’s disease. J Am Pharm Assoc. 2008;48:715–21.CrossRef
8.
go back to reference Galt KA, Fuji KT, Faber J. Patient safety problem identification and solution sharing among rural community pharmacists. J Am Pharm Assoc. 2013;53:584–94.CrossRef Galt KA, Fuji KT, Faber J. Patient safety problem identification and solution sharing among rural community pharmacists. J Am Pharm Assoc. 2013;53:584–94.CrossRef
9.
go back to reference Rickles NM, Skelton JB, Davis J, Hopson J. Cognitive memory screening and referral program in community pharmacies in the United States. Int J Clin Pharm. 2014;36:360–7.CrossRefPubMed Rickles NM, Skelton JB, Davis J, Hopson J. Cognitive memory screening and referral program in community pharmacies in the United States. Int J Clin Pharm. 2014;36:360–7.CrossRefPubMed
11.
go back to reference Caruana-Pulpan O, Scerri C. Practices in diagnosis, disclosure and pharmacotherapeutic management of dementia by general practitioners—a national survey. Aging Ment Health. 2014;18:179–86.CrossRefPubMed Caruana-Pulpan O, Scerri C. Practices in diagnosis, disclosure and pharmacotherapeutic management of dementia by general practitioners—a national survey. Aging Ment Health. 2014;18:179–86.CrossRefPubMed
12.
go back to reference Cerejeira J, Lagarto L, Mukaetova-Ladinska EB. Behavioral and psychological symptoms of dementia. Front Neurol. 2012;7:73. Cerejeira J, Lagarto L, Mukaetova-Ladinska EB. Behavioral and psychological symptoms of dementia. Front Neurol. 2012;7:73.
14.
go back to reference Carpenter BD, Balsis S, Otilingam PG, Hanson PK, Gatz M. The Alzheimer’s Disease Knowledge Scale: development and psychometric properties. Gerontologist. 2009;49:236–47.CrossRefPubMedPubMedCentral Carpenter BD, Balsis S, Otilingam PG, Hanson PK, Gatz M. The Alzheimer’s Disease Knowledge Scale: development and psychometric properties. Gerontologist. 2009;49:236–47.CrossRefPubMedPubMedCentral
15.
go back to reference Polit DF, Beck CT. Essentials of nursing research: appraising evidence for nursing practice. 7th ed. Philadelphia: Lippincott; 2010. Polit DF, Beck CT. Essentials of nursing research: appraising evidence for nursing practice. 7th ed. Philadelphia: Lippincott; 2010.
16.
go back to reference Scerri A, Scerri C. Nursing students’ knowledge and attitudes towards dementia—a questionnaire survey. Nurse Educ Today. 2013;33:962–8.CrossRefPubMed Scerri A, Scerri C. Nursing students’ knowledge and attitudes towards dementia—a questionnaire survey. Nurse Educ Today. 2013;33:962–8.CrossRefPubMed
17.
go back to reference Nordhus IH, Sivertsen B, Pallesen S. Knowledge about Alzheimer’s disease among Norwegian psychologists. Aging Ment Health. 2012;16:521–8.CrossRefPubMed Nordhus IH, Sivertsen B, Pallesen S. Knowledge about Alzheimer’s disease among Norwegian psychologists. Aging Ment Health. 2012;16:521–8.CrossRefPubMed
18.
go back to reference Smyth W, Fielding E, Beattie E, Gardner A, Moyle W, Franklin S, et al. A survey-based study of knowledge of Alzheimer’s disease among health care staff. BMC Geriatr. 2013;13:2.CrossRefPubMedPubMedCentral Smyth W, Fielding E, Beattie E, Gardner A, Moyle W, Franklin S, et al. A survey-based study of knowledge of Alzheimer’s disease among health care staff. BMC Geriatr. 2013;13:2.CrossRefPubMedPubMedCentral
19.
go back to reference Koch T, Iliffe S. EVIDEM-ED project. Rapid appraisal of barriers to the diagnosis and management of patients with dementia in primary care: a systemic review. BMC Fam Pract. 2010;11:52.CrossRefPubMedPubMedCentral Koch T, Iliffe S. EVIDEM-ED project. Rapid appraisal of barriers to the diagnosis and management of patients with dementia in primary care: a systemic review. BMC Fam Pract. 2010;11:52.CrossRefPubMedPubMedCentral
20.
go back to reference de la Torre JC. Basics of Alzheimer’s disease prevention. J Alzheimers Dis. 2010;20:687–8.PubMed de la Torre JC. Basics of Alzheimer’s disease prevention. J Alzheimers Dis. 2010;20:687–8.PubMed
21.
go back to reference Herrmann N, Chau SA, Kircanski I, Lanctot KIL. Current and emerging drug treatment options for Alzheimer’s disease: a systemic review. Drugs. 2011;71:2031–65.CrossRefPubMed Herrmann N, Chau SA, Kircanski I, Lanctot KIL. Current and emerging drug treatment options for Alzheimer’s disease: a systemic review. Drugs. 2011;71:2031–65.CrossRefPubMed
22.
go back to reference Stella F, Radanovic M, Canineu PR, de Paula VJ, Forlenza OV. Anti-dementia medications: current prescriptions in clinical practice and new agents in progress. Ther Adv Drug Saf. 2015;6:151–65.CrossRefPubMedPubMedCentral Stella F, Radanovic M, Canineu PR, de Paula VJ, Forlenza OV. Anti-dementia medications: current prescriptions in clinical practice and new agents in progress. Ther Adv Drug Saf. 2015;6:151–65.CrossRefPubMedPubMedCentral
24.
go back to reference Mort JR, Gaspar P, Pulscher S, Laird L. Management of demented patients within the community: techniques utilized and the impact of education. Clin Gerontol. 1993;13:23–45.CrossRef Mort JR, Gaspar P, Pulscher S, Laird L. Management of demented patients within the community: techniques utilized and the impact of education. Clin Gerontol. 1993;13:23–45.CrossRef
26.
go back to reference Rojas-Fernandez CH, Eng M, Allie ND. Pharmacologic management by clinical pharmacists of behavioural and psychological symptoms of dementia in nursing home residents: results from a pilot study. Pharmacotherapy. 2003;23:217–21.CrossRefPubMed Rojas-Fernandez CH, Eng M, Allie ND. Pharmacologic management by clinical pharmacists of behavioural and psychological symptoms of dementia in nursing home residents: results from a pilot study. Pharmacotherapy. 2003;23:217–21.CrossRefPubMed
27.
go back to reference Schmidt I, Claesson CB, Westerholm B, Nilsson LG, Svarstad BL. The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J Am Geriatr Soc. 1998;46:77–82.CrossRefPubMed Schmidt I, Claesson CB, Westerholm B, Nilsson LG, Svarstad BL. The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J Am Geriatr Soc. 1998;46:77–82.CrossRefPubMed
28.
go back to reference Westbury J, Jackson S, Gee P, Peterson G. An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUSe project. Int Psychogeriatr. 2010;22:26–36.CrossRefPubMed Westbury J, Jackson S, Gee P, Peterson G. An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUSe project. Int Psychogeriatr. 2010;22:26–36.CrossRefPubMed
Metadata
Title
Knowledge and pharmacological management of Alzheimer’s disease by managing community pharmacists: a nationwide study
Authors
Natalie Zerafa
Charles Scerri
Publication date
01-12-2016
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 6/2016
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-016-0380-8

Other articles of this Issue 6/2016

International Journal of Clinical Pharmacy 6/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.